Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study

Gian Battista Fausto Bolis; G Scarfone; F Raspagliesi; G Mangili; S Danese; P Scollo; D Lo Russo; A Villa; Pd Aimone; Giovanni Scambia

doi:10.1016/j.ejca.2010.06.124

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study

Gian Battista Fausto Bolis, G Scarfone, F Raspagliesi, G Mangili, S Danese, P Scollo, D Lo Russo, A Villa, Pd Aimone, Giovanni Scambia

Risultato della ricerca: Contributo in rivista › Articolo

36 Citazioni (Scopus)

Abstract

The objective of this prospective randomized phase III trial was to compare paclitaxel plus carboplatin (PC) versus topotecan plus carboplatin and paclitaxel (TPC) in women with suboptimal stage III (residual tumour >1cm) or stage IV ovarian cancer to evaluate the survival rate and toxicities.

Lingua originale	Inglese
pagine (da-a)	2905-2912
Numero di pagine	8
Rivista	European journal of cancer (Oxford, England : 1990)
Volume	46
DOI	https://doi.org/10.1016/j.ejca.2010.06.124
Stato di pubblicazione	Pubblicato - 2010

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Middle Aged
Ovarian Neoplasms
Paclitaxel
Topotecan
Treatment Outcome
Young Adult

Accesso al documento

10.1016/j.ejca.2010.06.124

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Bolis, G. B. F., Scarfone, G., Raspagliesi, F., Mangili, G., Danese, S., Scollo, P., Lo Russo, D., Villa, A., Aimone, P., & Scambia, G. (2010). Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study. European journal of cancer (Oxford, England : 1990), 46, 2905-2912. https://doi.org/10.1016/j.ejca.2010.06.124

@article{712d68e325774037815ad2f705eb1f4b,

title = "Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study",

abstract = "The objective of this prospective randomized phase III trial was to compare paclitaxel plus carboplatin (PC) versus topotecan plus carboplatin and paclitaxel (TPC) in women with suboptimal stage III (residual tumour >1cm) or stage IV ovarian cancer to evaluate the survival rate and toxicities.",

keywords = "Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Middle Aged, Ovarian Neoplasms, Paclitaxel, Topotecan, Treatment Outcome, Young Adult, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Middle Aged, Ovarian Neoplasms, Paclitaxel, Topotecan, Treatment Outcome, Young Adult",

author = "Bolis, \{Gian Battista Fausto\} and G Scarfone and F Raspagliesi and G Mangili and S Danese and P Scollo and \{Lo Russo\}, D and A Villa and Pd Aimone and Giovanni Scambia",

year = "2010",

doi = "10.1016/j.ejca.2010.06.124",

language = "English",

volume = "46",

pages = "2905--2912",

journal = "European journal of cancer (Oxford, England : 1990)",

}

Bolis, GBF, Scarfone, G, Raspagliesi, F, Mangili, G, Danese, S, Scollo, P, Lo Russo, D, Villa, A, Aimone, P & Scambia, G 2010, 'Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study', European journal of cancer (Oxford, England : 1990), vol. 46, pagg. 2905-2912. https://doi.org/10.1016/j.ejca.2010.06.124

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study. / Bolis, Gian Battista Fausto; Scarfone, G; Raspagliesi, F et al.
In: European journal of cancer (Oxford, England : 1990), Vol. 46, 2010, pag. 2905-2912.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study

AU - Bolis, Gian Battista Fausto

AU - Scarfone, G

AU - Raspagliesi, F

AU - Mangili, G

AU - Danese, S

AU - Scollo, P

AU - Lo Russo, D

AU - Villa, A

AU - Aimone, Pd

AU - Scambia, Giovanni

PY - 2010

Y1 - 2010

N2 - The objective of this prospective randomized phase III trial was to compare paclitaxel plus carboplatin (PC) versus topotecan plus carboplatin and paclitaxel (TPC) in women with suboptimal stage III (residual tumour >1cm) or stage IV ovarian cancer to evaluate the survival rate and toxicities.

AB - The objective of this prospective randomized phase III trial was to compare paclitaxel plus carboplatin (PC) versus topotecan plus carboplatin and paclitaxel (TPC) in women with suboptimal stage III (residual tumour >1cm) or stage IV ovarian cancer to evaluate the survival rate and toxicities.

KW - Adult

KW - Aged

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Carboplatin

KW - Disease-Free Survival

KW - Female

KW - Humans

KW - Kaplan-Meier Estimate

KW - Middle Aged

KW - Ovarian Neoplasms

KW - Paclitaxel

KW - Topotecan

KW - Treatment Outcome

KW - Young Adult

KW - Adult

KW - Aged

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Carboplatin

KW - Disease-Free Survival

KW - Female

KW - Humans

KW - Kaplan-Meier Estimate

KW - Middle Aged

KW - Ovarian Neoplasms

KW - Paclitaxel

KW - Topotecan

KW - Treatment Outcome

KW - Young Adult

UR - http://hdl.handle.net/10807/32508

U2 - 10.1016/j.ejca.2010.06.124

DO - 10.1016/j.ejca.2010.06.124

M3 - Article

VL - 46

SP - 2905

EP - 2912

JO - European journal of cancer (Oxford, England : 1990)

JF - European journal of cancer (Oxford, England : 1990)

ER -

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo